A doença de Kikuchi-Fujimoto é caracterizada por febre e linfadenopatia, geralmente . Enfermedad de Kikuchi-Fujimoto (linfadenitis necrotizante histiocitaria). La enfermedad de Kikuchi Fujimoto se caracteriza histológicamente por la presencia de linfadenitis necrotizante, que igualmente se encuentra descrita en. Referencias bibliográficas. 1. R.F. DorfmanHistiocytic necrotizing lymphadenitis of Kikuchi and Fujimoto [editorial]. Arch Pathol Lab Med, (), pp.
|Published (Last):||20 August 2011|
|PDF File Size:||2.57 Mb|
|ePub File Size:||19.51 Mb|
|Price:||Free* [*Free Regsitration Required]|
Subscriber If you already have your login data, please click here. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. The magazine, referring to the Spanish-speaking pediatric, indexed in major international databases: Histopathology Enfermdead organ diseases Lymphoid-related cutaneous conditions Rare diseases.
Enfermedad de Kikuchi-Fujimoto
Proc Bayl Univ Med Cent. J Comput Assist Tomogr, 23pp.
How to cite this article. Some studies have suggested a genetic predisposition to the proposed autoimmune response. Natl Med J India.
No specific cure is known. A pesquisa de BAAR foi negativa. Orphanet J Rare Dis. Awareness of this disorder helps prevent misdiagnosis and inappropriate treatment. Os sinais e sintomas resolvem geralmente dentro de 4 meses. A clinico-pathologic study of 45 cases with in situ hybridization for Epstein-Barr virus and hepatitis B virus. Orphanet J Rare Dis.
Kikuchi disease – Wikipedia
KFD is now proposed to be a nonspecific hyperimmune reaction to a variety of infectious, chemical, physical, and neoplastic agents. If the clinical course is more severe, with multiple flares of bulky enlarged cervical lymph nodes and fever, then a low-dose corticosteroid treatment has been suggested. Antinuclear antibodiesantiphospholipid antibodiesanti-dsDNAand rheumatoid factor are usually negative, and may help in differentiation from systemic lupus erythematosus. Archived from the original on The course of the disease is generally benign and self-limiting.
Treatment is largely supportive. SRJ is a prestige metric based on the idea that not all citations are the same. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.
Continuing navigation will be considered as acceptance of this use. Kikuchi-Fujimoto necrotizing lymphadenitis associated with brucellosis [Article in Spanish]. Print Send to a friend Export reference Mendeley Statistics. SRJ is a prestige metric based on the idea that not all citations are the same. Kikuchi’s disease is a very rare disease mainly seen in Japan. Aetiology of peripheral lymphadenopathy in adults: The differential diagnosis of Kikuchi disease includes systemic lupus erythematosus SLEdisseminated tuberculosislymphomasarcoidosisand viral lymphadenitis.
Pediatrics,pp. You can change the settings or obtain more information by clicking here. UpToDate [cited Aug, version Hospital Regional Universitario Infanta Cristina. Nonsteroidal anti-inflammatory drugs NSAIDs are indicated for tender lymph nodes and fever, and corticosteroids are useful in severe extranodal or generalized disease.
Necrotizing cervical lymphadenopathy caused by Kikuchi-Fujimoto disease. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a fuuimoto field. You can change the settings or obtain more information by clicking here.
The Spanish Association of Pediatrics has as one of its main objectives the dissemination of rigorous and updated scientific information on the different areas of pediatrics. Cervical subacute necrotizing lymphadenitis. Unusual systemic disorders associated with interstitial lung disease. Alguns autores descreveram 25 casos de DKF. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.